BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32319226)

  • 1. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
    Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
    J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
    Yang L; Jing J; Sun L; Yue Y
    Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
    Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
    Hereditas; 2019; 156():20. PubMed ID: 31285741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
    Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
    Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
    Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
    J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognosis-related hub genes of ovarian cancer through bioinformatics analyses and experimental verification.
    Yu Z; Ouyang L
    Medicine (Baltimore); 2022 Sep; 101(36):e30374. PubMed ID: 36086731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
    Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
    Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis.
    Tang J; Kong D; Cui Q; Wang K; Zhang D; Gong Y; Wu G
    Front Oncol; 2018; 8():374. PubMed ID: 30254986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.
    Xu X; Xu L; Huang H; Li J; Dong S; Jin L; Ma Z; Li L
    Biomed Res Int; 2020; 2020():3416807. PubMed ID: 32596300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis.
    Chi Q; Geng X; Xu K; Wang C; Zhao H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.